Cargando…

Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment

Despite significant improvement of neuroblastoma (NB) patients’ survival due to recent treatment advancements in recent years, NB is still associated with high mortality rate. In search of novel strategies to increase NB’s susceptibility to pharmacological treatments, we investigated the in vitro an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brizzolara, Antonella, Garbati, Patrizia, Vella, Serena, Calderoni, Matilde, Quattrone, Alessandro, Tonini, Gian Paolo, Capasso, Mario, Longo, Luca, Barbieri, Raffaella, Florio, Tullio, Pagano, Aldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698186/ https://www.ncbi.nlm.nih.gov/pubmed/33182713 http://dx.doi.org/10.3390/molecules25225234

Ejemplares similares

Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice
por: Garbati, Patrizia, et al.
Publicado: (2021)

Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA
por: Vella, Serena, et al.
Publicado: (2015)

MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment
por: Garbati, Patrizia, et al.
Publicado: (2020)

An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma
por: Baldini, Francesca, et al.
Publicado: (2021)

PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs
por: Vella, Serena, et al.
Publicado: (2016)

The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells
por: Penna, Ilaria, et al.
Publicado: (2016)

Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA
por: Costa, Delfina, et al.
Publicado: (2014)

Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling
por: Woods, Neha, et al.
Publicado: (2015)

CHEMOTHERAPEUTIC STUDIES WITH ETHYLHYDROCUPREINE HYDROCHLORIDE IN EXPERIMENTAL PNEUMOCOCCUS PLEURITIS
por: Kolmer, John A., et al.
Publicado: (1921)

Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies
por: Bajetto, Adriana, et al.
Publicado: (2020)

Translational compensation of genomic instability in neuroblastoma
por: Dassi, Erik, et al.
Publicado: (2015)

Evaluation of Fendiline Treatment in VP40 System with Nucleation-Elongation Process: A Computational Model of Ebola Virus Matrix Protein Assembly
por: Liu, Xiao, et al.
Publicado: (2023)

Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity
por: Barbieri, Federica, et al.
Publicado: (2019)

Multi-omic profiling of MYCN-amplified neuroblastoma cell-lines
por: Dassi, Erik, et al.
Publicado: (2015)

Impact of Interleukin-6 –174 G>C Gene Promoter Polymorphism on Neuroblastoma
por: Totaro, Francesca, et al.
Publicado: (2013)

Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
por: Alhothali, Marwa, et al.
Publicado: (2019)

Neuroblastoma by chance
por: Tonini, Gian Paolo
Publicado: (2019)

Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells
por: Gong, Baocheng, et al.
Publicado: (2021)

A p53 Drug Response Signature Identifies Prognostic Genes in High-Risk Neuroblastoma
por: Barbieri, Eveline, et al.
Publicado: (2013)

A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma
por: De Mariano, Marilena, et al.
Publicado: (2017)

Potential Risks of Plant Constituents in Dietary Supplements: Qualitative and Quantitative Analysis of Peganum harmala Seeds
por: Calderoni, Matilde, et al.
Publicado: (2021)

Liquid Chromatographic Resolution of Fendiline and Its Analogues on a Chiral Stationary Phase Based on (+)-(18-Crown-6)-2,3,11,12-tetracarboxylic Acid
por: Lee, Ga Ram, et al.
Publicado: (2014)

SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro
por: Tümmler, Conny, et al.
Publicado: (2019)

Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells
por: Gong, Baocheng, et al.
Publicado: (2022)

Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
por: García-Rodríguez, Francisco Javier, et al.
Publicado: (2018)

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma
por: Formicola, Daniela, et al.
Publicado: (2016)

Chromosome instability in neuroblastoma
por: Fusco, Pina, et al.
Publicado: (2018)

Why Is Aneuploidy Associated with Favorable Outcome in Neuroblastoma?
por: Tonini, Gian Paolo
Publicado: (2021)

YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
por: Yang, Chao, et al.
Publicado: (2017)

Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells
por: Rodrigo, Miguel Angel Merlos, et al.
Publicado: (2019)

Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma
por: Gunda, Venugopal, et al.
Publicado: (2020)

Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma
por: Avitabile, Marianna, et al.
Publicado: (2020)

Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
por: Rodrigo, Miguel Angel Merlos, et al.
Publicado: (2021)

Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
por: Yang, Chao, et al.
Publicado: (2022)

Role of Chemokine Network in the Development and Progression of Ovarian Cancer: A Potential Novel Pharmacological Target
por: Barbieri, Federica, et al.
Publicado: (2010)

New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells
por: Würth, Roberto, et al.
Publicado: (2014)

A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma
por: Calabrese, Francesco Maria, et al.
Publicado: (2016)

Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis?
por: Tonini, Gian Paolo
Publicado: (2017)

Neuroblastoma treatment in the post-genomic era
por: Esposito, Maria Rosaria, et al.
Publicado: (2017)

A Novel Collection of snRNA-Like Promoters with Tissue-Specific Transcription Properties
por: Garritano, Sonia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_89ahdjs5kr84g267oui70a2uni